TMEM184B Antilichaam

TMEM184B Antibody: TMEM184B, also known as C22orf5, is a 407 amino acid multi-pass membrane protein and represents a novel gene in the activation of the MAPK signaling pathway. The gene encoding TMEM184B maps to human chromosome 22; mutations in several of the genes in chromosome 22 are involved in the development of autism, schizophrenia, Phelan-McDermid syndrome and Neurofibromatosis type 2, suggesting that TMEM184B may play a role in these syndromes.

25829

Q9Y519

NP_036396

Human, Mouse, Rat

Unconjugated

Primary Antibodies

Signal Transduction

TMEM184B Antibody is affinity chromatography purified via peptide column.

Cat. No. 1462 - Rat Lung Tissue Lysate

1 mg/mL

Predicted species reactivity based on immunogen sequence: Bovine: (100%)

TMEM184B Antibody is supplied in PBS containing 0.02% sodium azide.

None

Blue Ice

TMEM184B antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

IgG

TMEM184B

Cat. No. 10-101 - Human Lung Tissue Slide

Transmembrane protein 184B

Homo sapiens

Matsuda A, Suzuki Y, Honda G, et al. Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene2003; 22:3307-18.

Dunham I, Shimizu N, Roe BA, et al. The DNA sequence of human chromosome 2. Nature1999; 402:489-495.

TMEM184B Antibody: FM08, HS5O6A, C22orf5, PSEC0108, Transmembrane protein 184B, Putative MAPK-activating protein FM08

ELISA, WB, IHC-P, IF

63259329

Liquid